A detailed history of Cra Financial Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cra Financial Services, LLC holds 11,428 shares of ABBV stock, worth $1.96 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
11,428
Previous 11,418 0.09%
Holding current value
$1.96 Million
Previous $1.77 Million 17.64%
% of portfolio
0.47%
Previous 0.45%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$159.82 - $182.1 $1,598 - $1,821
10 Added 0.09%
11,428 $2.08 Million
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $3,715 - $4,184
27 Added 0.24%
11,418 $1.77 Million
Q3 2023

Oct 13, 2023

BUY
$133.59 - $154.65 $314,604 - $364,200
2,355 Added 26.06%
11,391 $1.7 Million
Q2 2023

Jul 11, 2023

BUY
$132.51 - $164.9 $21,466 - $26,713
162 Added 1.83%
9,036 $1.22 Million
Q1 2023

Apr 06, 2023

BUY
$144.61 - $166.54 $40,635 - $46,797
281 Added 3.27%
8,874 $1.41 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $53,525 - $64,191
-387 Reduced 4.31%
8,593 $0
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 1.1%
8,980 $1.21 Million
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $2,752 - $3,499
20 Added 0.22%
9,080 $1.39 Million
Q1 2022

Apr 15, 2022

BUY
$131.98 - $163.75 $255,909 - $317,511
1,939 Added 27.23%
9,060 $1.47 Million
Q4 2021

Jan 20, 2022

SELL
$107.43 - $135.93 $5,156 - $6,524
-48 Reduced 0.67%
7,121 $964,000
Q3 2021

Oct 12, 2021

BUY
$106.4 - $120.78 $43,624 - $49,519
410 Added 6.07%
7,169 $773,000
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $110,260 - $122,836
1,048 Added 18.35%
6,759 $761,000
Q1 2021

Apr 16, 2021

SELL
$102.3 - $112.62 $716 - $788
-7 Reduced 0.12%
5,711 $618,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $25,676 - $34,665
319 Added 5.91%
5,718 $613,000
Q3 2020

Oct 14, 2020

SELL
$85.91 - $100.83 $14,862 - $17,443
-173 Reduced 3.1%
5,399 $473,000
Q2 2020

Jul 22, 2020

BUY
$73.37 - $98.18 $14,600 - $19,537
199 Added 3.7%
5,572 $547,000
Q1 2020

Apr 14, 2020

BUY
$64.5 - $97.79 $19,414 - $29,434
301 Added 5.93%
5,373 $409,000
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $123,125 - $154,056
1,707 Added 50.73%
5,072 $449,000
Q3 2019

Nov 07, 2019

BUY
$62.98 - $75.72 $19,460 - $23,397
309 Added 10.11%
3,365 $255,000
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $2,430 - $3,107
-37 Reduced 1.2%
3,056 $222,000
Q1 2019

Apr 15, 2019

BUY
$77.14 - $90.79 $46,129 - $54,292
598 Added 23.97%
3,093 $249,000
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $194,235 - $239,544
2,495 New
2,495 $230,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cra Financial Services, LLC Portfolio

Follow Cra Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.